Wedbush Calls Palantir a Top Stock to Own in 2025 | Global News Avenue

Wedbush analysts call Palantir (bacteria) One of their “names to have in 2025”.

Palantir shares rose more than 6% early on Monday, before cutting earnings to 1.8%. The stock has increased by about 10% since the beginning of the year, and despite recent losses, its value a year ago has more than tripled compared to a year ago.

Since hitting record highs last month Washington Post Reports said the Trump administration directed Pentagon officials Trim the U.S. Defense Budget Over the next five years, it reached 8% per year. The report sparked concerns about sales as the federal government represented Palantir’s major customers, accounting for more than 40% of its revenue in the fourth quarter.

But Wedbush analysts told clients on Monday that they expect Palantir’s AI platform, and that the Trump administration’s focus on efficiency could put the company in the “best place to benefit from tidal federal spending on AI”, which could benefit the company even if other government contractors face spending cuts. “We think Palantir can actually get more transactions and IT budget dollars in various government agencies,” the analyst added.

Wedbush maintained its “outperform” rating and a stock target of $120, closing above 40% on Monday at $83.42.

Several other analysts have expressed similar emotions in recent weeks. Recommended last month A better position than most people can benefit from the department of government efficiency led by Elon Musk Targets for reducing spending.

Updated – March 3, 2025: This article has been updated since its first release to reflect the newer share price value.